Hannah K. Oakes
Research Subjects
Research Interests
Hannah K. Oakes has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Christopher Garrett Ballmann
University of Alabama at Birmingham, Birmingham, AL
2 shared publications - Daphne G. Schmid
Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL 32611, USA
2 shared publications - Shelby C. Osburn
Department of Human Studies, University of Alabama at Birmingham, Birmingham, AL 35294, USA
2 shared publications - Ashley A. Sizemore
Department of Human Studies, University of Alabama at Birmingham, Birmingham, AL 35294, USA
1 shared publication - Emily S. Pounds
Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL 35294, USA
1 shared publication - Maggie M. Pitts
Department of Human Studies, University of Alabama at Birmingham, Birmingham, AL 35294, USA
1 shared publication
Latest Publications
- Open Access
- 4 June 2026
- Published by MDPI AG in International Journal of Cognitive Sciences
- Vol. 2 (2) , 14
Music Interventions and Non-Cognitive Symptoms of Alzheimer’s Disease: An Integrative and Narrative Review
Alzheimer’s disease (AD) results in progressive neural degeneration that causes cognitive and non-cognitive symptoms (NCSs). While cognitive symptoms commonly prompt a formal diagnosis, NCSs also contribute significantly to disability, caregiver burden, and overall disease progression. NCSs are rooted in both physiological and psychological consequences of AD, resulting in apathy/motivation loss, emotional dysregulation, anxiety, depression, agitation, and sleep disturbances. Despite progresses in pharmaceutical management of NCSs, variable efficacy, unwanted side effects, and lack of symptom-wide effectiveness often limit therapeutic practicality for people with AD, suggesting a need for the identification of practical adjunctive treatments. Mechanistic evidence of using music interventions as complementary treatment to manage cognitive symptoms in AD has been established, but the potential benefits for NCSs are less clear. Music interventions have the potential to adaptatively alter mechanisms underlying NCSs that span both physiological and psychological domains of symptomology. Physiologically, music has been shown to alter autonomic activity, neurotransmitter release in various brain regions, and mediate hormonal regulation. Psychologically, music interventions have been shown to enhance mechanisms related to motivation, emotional regulation, and resilience to mental stress. Behavioral and neuroimaging evidence further supports this and suggests that the mechanisms of music-induced benefits may aid in counteracting NCSs in people with AD. While the neuromechanistic rationale for music-induced benefits towards NCSs in AD is promising, findings are largely fragmented, leaving therapeutic application difficult. Accordingly, the purpose of this review is to integrate current mechanistic evidence and clinical findings for a rationale and framework for the therapeutic application of music interventions to combat NCSs in AD. Overall, evidence largely supports the use of music as an adjunctive, feasible, and non-invasive therapeutic tool to improve various aspects of NCSs in AD. The translation of mechanistic findings to therapeutic utility are further highlighted. Limitations, challenges, and future directions necessary to fully realize music benefits on NCSs in AD are also discussed with a goal of therapeutic translation.
- 4 June 2026
- Published by MDPI AG in International Journal of Cognitive Sciences
- Vol. 2 (2) , 14
Open AccessMusic Interventions and Non-Cognitive Symptoms of Alzheimer’s Disease: An Integrative and Narrative Review
Alzheimer’s disease (AD) results in progressive neural degeneration that causes cognitive and non-cognitive symptoms (NCSs). While cognitive symptoms commonly prompt a formal diagnosis, NCSs also contribute significantly to disability, caregiver burden, and overall disease progression. NCSs are rooted in both physiological and psychological consequences of AD, resulting in apathy/motivation loss, emotional dysregulation, anxiety, depression, agitation, and sleep disturbances. Despite progresses in pharmaceutical management of NCSs, variable efficacy, unwanted side effects, and lack of symptom-wide effectiveness often limit therapeutic practicality for people with AD, suggesting a need for the identification of practical adjunctive treatments. Mechanistic evidence of using music interventions as complementary treatment to manage cognitive symptoms in AD has been established, but the potential benefits for NCSs are less clear. Music interventions have the potential to adaptatively alter mechanisms underlying NCSs that span both physiological and psychological domains of symptomology. Physiologically, music has been shown to alter autonomic activity, neurotransmitter release in various brain regions, and mediate hormonal regulation. Psychologically, music interventions have been shown to enhance mechanisms related to motivation, emotional regulation, and resilience to mental stress. Behavioral and neuroimaging evidence further supports this and suggests that the mechanisms of music-induced benefits may aid in counteracting NCSs in people with AD. While the neuromechanistic rationale for music-induced benefits towards NCSs in AD is promising, findings are largely fragmented, leaving therapeutic application difficult. Accordingly, the purpose of this review is to integrate current mechanistic evidence and clinical findings for a rationale and framework for the therapeutic application of music interventions to combat NCSs in AD. Overall, evidence largely supports the use of music as an adjunctive, feasible, and non-invasive therapeutic tool to improve various aspects of NCSs in AD. The translation of mechanistic findings to therapeutic utility are further highlighted. Limitations, challenges, and future directions necessary to fully realize music benefits on NCSs in AD are also discussed with a goal of therapeutic translation.
- Open Access
- 26 February 2026
- Published by MDPI AG in Neurology International
- Vol. 18 (3) , 45
Potential Effects of Music on Non-Motor Symptoms in Parkinson’s Disease: Translating Mechanisms to Therapy
Non-motor symptoms (NMSs) are highly prevalent in Parkinson’s Disease (PD) and contribute significantly to disease severity, progression, and diminished quality of life. NMSs are rooted in both physiological and psychological domains and include emotional dysfunction, autonomic dysregulation, cognitive impairment, pain exacerbation, and neural deficits. While pharmacological approaches are often employed for the alleviation of non-motor symptomology, modest efficacy and adverse side effects may limit their practical utility for individuals with PD, leaving the need for the identification of complementary approaches. Music interventions have emerged as potential adjunctive therapeutic approaches that may positively modulate NMSs in both physiological and psychological domains. Physiologically, music interventions have been shown to alter autonomic activity and pain/sensory perceptions and mediate neurotransmitter release related to arousal, physical effort, and stress. Psychologically, music interventions, both passive and active, have been shown to modulate emotional regulation, motivation, attention, and cognitive performance. Emerging evidence utilizing neuroimaging and behavioral techniques further supports this and suggests music-induced benefits even in the presence of advancing neurodegeneration. Overall, findings from this narrative review suggest music may serve as a potential non-invasive adjunctive therapeutic tool to counteract PD-induced NMSs by adaptively modulating physiological and psychological processes. This narrative review aims to gather current evidence on the physiological and psychological mechanisms underlying the benefits of music and proposes potential therapeutic translation for NMSs in PD. Furthermore, current difficulties, gaps in knowledge, and needs for future research are discussed with the goal of informing directions for clinical translation.
- 26 February 2026
- Published by MDPI AG in Neurology International
- Vol. 18 (3) , 45
Open AccessPotential Effects of Music on Non-Motor Symptoms in Parkinson’s Disease: Translating Mechanisms to Therapy
Non-motor symptoms (NMSs) are highly prevalent in Parkinson’s Disease (PD) and contribute significantly to disease severity, progression, and diminished quality of life. NMSs are rooted in both physiological and psychological domains and include emotional dysfunction, autonomic dysregulation, cognitive impairment, pain exacerbation, and neural deficits. While pharmacological approaches are often employed for the alleviation of non-motor symptomology, modest efficacy and adverse side effects may limit their practical utility for individuals with PD, leaving the need for the identification of complementary approaches. Music interventions have emerged as potential adjunctive therapeutic approaches that may positively modulate NMSs in both physiological and psychological domains. Physiologically, music interventions have been shown to alter autonomic activity and pain/sensory perceptions and mediate neurotransmitter release related to arousal, physical effort, and stress. Psychologically, music interventions, both passive and active, have been shown to modulate emotional regulation, motivation, attention, and cognitive performance. Emerging evidence utilizing neuroimaging and behavioral techniques further supports this and suggests music-induced benefits even in the presence of advancing neurodegeneration. Overall, findings from this narrative review suggest music may serve as a potential non-invasive adjunctive therapeutic tool to counteract PD-induced NMSs by adaptively modulating physiological and psychological processes. This narrative review aims to gather current evidence on the physiological and psychological mechanisms underlying the benefits of music and proposes potential therapeutic translation for NMSs in PD. Furthermore, current difficulties, gaps in knowledge, and needs for future research are discussed with the goal of informing directions for clinical translation.